Cargando…
Practical leadership for biopharmaceutical executives /
The biohealthcare executive in upper-middle management confronts leadership challenges unique to their industry: they manage highly specialized knowledge workers and innovators, compete at the speed of technology, work in a highly regulated environment where "free speech" often does not ap...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge, UK ; Philadelphia, PA :
Biohealthcare Pub.,
2011.
|
| Colección: | Woodhead Publishing series in biomedicine.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn880900663 | ||
| 003 | OCoLC | ||
| 005 | 20231117044830.0 | ||
| 006 | m o d | ||
| 007 | cr unu|||||||| | ||
| 008 | 140603s2011 enka ob 001 0 eng d | ||
| 040 | |a UMI |b eng |e pn |c UMI |d YDXCP |d OCLCO |d OPELS |d DEBSZ |d EBLCP |d OCLCQ |d OCLCF |d U3W |d D6H |d ESU |d WYU |d UAB |d AUD |d AU@ |d UKAHL |d OCLCQ |d S2H |d OCLCO |d OCLCQ |d CASUM | ||
| 019 | |a 827454915 |a 866858684 | ||
| 020 | |a 9781908818027 | ||
| 020 | |a 1908818026 | ||
| 020 | |z 9781907568060 | ||
| 020 | |z 1907568069 | ||
| 035 | |a (OCoLC)880900663 |z (OCoLC)827454915 |z (OCoLC)866858684 | ||
| 050 | 4 | |a HD9665.5 |b .C47 2011 | |
| 082 | 0 | 4 | |a 658.4092 |2 22 |
| 100 | 1 | |a Chin, Jane Y. | |
| 245 | 1 | 0 | |a Practical leadership for biopharmaceutical executives / |c Jane Y. Chin. |
| 260 | |a Cambridge, UK ; |a Philadelphia, PA : |b Biohealthcare Pub., |c 2011. | ||
| 300 | |a 1 online resource (1 volume) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Woodhead publishing series in biomedicine | |
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a The biohealthcare executive in upper-middle management confronts leadership challenges unique to their industry: they manage highly specialized knowledge workers and innovators, compete at the speed of technology, work in a highly regulated environment where "free speech" often does not apply due to patient safety and privacy concerns, and increasingly are leading virtual teams who may be located in different parts of the world. Practical leadership for biopharmaceutical executives is a guide that strips away the theory and meets head-on the practical leadership challenges these executives face on a daily basis, and provides these "innovator leaders" with the tools to lead effectively in the face of technological complexity. Focuses on personal leadership, where the executive has an opportunity to manage his/her own effectiveness as a leader and manager, and engage with their own career development and method of contribution within their chosen industryDiscusses particularly the unique leadership challenges in biohealthcare: an industry that is at once highly innovative and emotive. Biohealthcare companies are often viewed with suspicion by the consumers who question corporate motives, and product marketing and sales practices. The effective biohealthcare leaders are well aware of these emotive features, and embody ethics through action - not just lip serviceIncludes real life examples, including a series of both phone-based and email-based interviews of executives | ||
| 505 | 0 | |a Cover; Practical leadership for biopharmaceutical executives; Copyright; Dedication; Contents; Acknowledgements; List of abbreviations; Author's note; About the author; 1'Leadership' as a phenomenon; Introduction; Qualitative research methodology; Data analysis; Conclusion; Objectives of this book; 2Seven managerial leadership competencies; Leadership competence versus capacity; Competence in role: competence for tasks required of the leadership role; Autonomy-cohesion: competence in imparting autonomy and creating cohesion; Trust: competence in creating trust and working from trust. | |
| 505 | 8 | |a Steadiness amid uncertainty: competence for effectiveness amid incomplete/imperfect facts and/or tensionBalanced execution: competence for balanced execution in the face of increased complexity of role; Communication: competence for expressing clearly, to the scale appropriate to the audience, and with the intended result; Growth/cultivation: competence for developing current and future capability in self and others; Conclusion; 3Three commitments of pharmaceutical executives: presence; Introduction; The purpose of maintaining presence; Motivating and energizing employees. | |
| 505 | 8 | |a Energized teams brim with ideasHow team creativity is compromised; A biopharmaceutical executive's communication awareness; Case illustrations of managerial communication failure; Debriefing the case illustrations; Contextual presence in corporate politics; Conclusion; Chapter summary; 4Three commitments of pharmaceutical executives: stewardship; Introduction; Authority to give people jobs (assign them tasks); Case illustrations of poor stewardship of managerial authority; Debriefing the case illustrations; Authority to give people objectives (assign a direction). | |
| 505 | 8 | |a Authority to serve industry and companyConclusion; Chapter summary; 5Three commitments of pharmaceutical executives: development; Introduction; Prerequisites in personnel development; How an executive uses the 'stretch' approach in development; Consistency of process in development; Individual contributor to first-line manager: key development challenges; Capabilities today, capabilities tomorrow; Spotlight on field medical science: a case of developing employees in a novel role; The biopharmaceutical executive's own leadership development; Knowing that one does not know: blindspots. | |
| 505 | 8 | |a ConclusionChapter summary; 6Self-concept as 'leader'; Introduction; Origin of leadership self-concept; Leadership self-concept in executives' managerial awareness; Role of structure in managerial leadership; Conclusion; 7Conclusion: a new model of biopharmaceutical executive leadership; Appendix 1 Executive demographics; Appendix 2 Aggregate descriptions of subjective experiences of leadership; Appendix 3 Sample interviewee descriptions for 'presence'; Appendix 4 Sample interviewee descriptions for 'stewardship'; Appendix 5 Sample interviewee descriptions for 'development' | |
| 650 | 0 | |a Pharmaceutical biotechnology industry |x Management. | |
| 650 | 0 | |a Executive ability. | |
| 650 | 0 | |a Leadership. | |
| 650 | 1 | 2 | |a Leadership. |
| 650 | 6 | |a Biotechnologie pharmaceutique |0 (CaQQLa)201-0344927 |x Industrie |0 (CaQQLa)201-0344927 |x Gestion. |0 (CaQQLa)201-0380063 | |
| 650 | 6 | |a Aptitude pour la direction. |0 (CaQQLa)201-0007398 | |
| 650 | 6 | |a Leadership. |0 (CaQQLa)201-0025113 | |
| 650 | 7 | |a Executive ability. |2 fast |0 (OCoLC)fst00917778 | |
| 650 | 7 | |a Leadership. |2 fast |0 (OCoLC)fst00994701 | |
| 655 | 4 | |a Internet Resources. | |
| 776 | 0 | 8 | |i Print version: |a Chin, Jane Y. |t Practical leadership for biopharmaceutical executives. |d Oxford : Biohealthcare Pub., 2011 |z 9781907568060 |w (DLC) 2011505934 |w (OCoLC)712636981 |
| 830 | 0 | |a Woodhead Publishing series in biomedicine. | |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9781907568060 |z Texto completo |